Journal Article

DKFZ-2024-02728

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study.

Almanza-Aguilera, E. ; Martínez-Huélamo, M. ; López-Hernández, Y. ; Guiñón-Fort, D. ; Guadall, A. ; Cruz, M. ; Perez-Cornago, A. ; Rostgaard-Hansen, A. L. ; Tjønneland, A. ; Dahm, C. C. ; Katzke, V.DKFZ* ; Schulze, M. B. ; Masala, G. ; Agnoli, C. ; Tumino, R. ; Ricceri, F. ; Lasheras, C. ; Crous-Bou, M. ; Sánchez, M.-J. ; Aizpurua-Atxega, A. ; Guevara, M. ; Tsilidis, K. K. ; Chatziioannou, A. C. ; Weiderpass, E. ; Travis, R. C. ; Wishart, D. S. ; Andrés-Lacueva, C. ; Zamora-Ros, R.

2024
MDPI Basel

This record in other databases:  

Please use a persistent id in citations: doi:10.3390/cancers16234116

Abstract: Background and Objective: Nutrimetabolomics may reveal novel insights into early metabolic alterations and the role of dietary exposures on prostate cancer (PCa) risk. We aimed to prospectively investigate the associations between plasma metabolite concentrations and PCa risk, including clinically relevant tumor subtypes. Methods: We used a targeted and large-scale metabolomics approach to analyze plasma samples of 851 matched PCa case-control pairs from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Associations between metabolite concentrations and PCa risk were estimated by multivariate conditional logistic regression analysis. False discovery rate (FDR) was used to control for multiple testing correction. Results: Thirty-one metabolites (predominately derivatives of food intake and microbial metabolism) were associated with overall PCa risk and its clinical subtypes (p < 0.05), but none of the associations exceeded the FDR threshold. The strongest positive and negative associations were for dimethylglycine (OR = 2.13; 95% CI 1.16-3.91) with advanced PCa risk (n = 157) and indole-3-lactic acid (OR = 0.28; 95% CI 0.09-0.87) with fatal PCa risk (n = 57), respectively; however, these associations did not survive correction for multiple testing. Conclusions: The results from the current nutrimetabolomics study suggest that apart from early metabolic deregulations, some biomarkers of food intake might be related to PCa risk, especially advanced and fatal PCa. Further independent and larger studies are needed to validate our results.

Keyword(s): EPIC ; nested case–control ; nutrimetabolomics ; prostate cancer

---

Contributing Institute(s):

1. C020 Epidemiologie von Krebs (C020)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2024

---

Database coverage:
; ; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---